Investors
Board and leadership
Key to committees/roles:
- E Executive
- N Nomination
- A Audit and Risk
- R Remuneration
- Chair
Peter Allen, BA (Hons) ACA
Non-Executive Chairman
Appointment: June 2018
- N
- R
Alan Hirzel MS, MBA
Chief Executive Officer
Appointment: January 2014
- E
Michael S Baldock, BA
Chief Financial Officer
Appointment: February 2020
- E
Giles Kerr, BSc ACA
Non-Executive Director and Senior Independent Director
Appointment: 12 December 2018
- N
- A
- R
Mara Aspinall, MBA
Non-Executive Director
Appointment: September 2015
- N
- A
- R
Mark Capone, MSc
Non-Executive Director
Appointment: 28 January 2021
- R
Bessie Lee, MS, BA
Non-Executive Director
Appointment: 28 January 2021
Sally W. Crawford
Non-Executive Director
Appointment: 13 August 2021
- R
- A
Luba Greenwood
Non-Executive Director
Appointment: 12 September 2022
Gender diversity
The percentage of women on the Board is currently 38%, putting us ahead of the recommended targets for FTSE 350 companies.
Whilst our percentage of women on the Board and on the executive leadership team ( decreased this year to 31% as at 30 June 2020 (36% as at 30 June 2019), we continue to seek to increase the pipeline of women into both the Board and senior management.
| Board skills and experience (data as of 30 June 2020) | Directors |
|---|---|
| Executive and strategic leadership | 7 |
| Extensive knowledge of our business and the life sciences sector | 6 |
| Broad international exposure, including in particular the United States and/or China | 6 |
| Experience in finance and accounting | 5 |
| Experience of acquisitions and integration of acquired businesses | 7 |
| Experience in corporate governance and compliance | 5 |
| Investor relations and engagement | 5 |
| Experience in relation to employee engagement and remuneration including incentive programmes | 5 |
| Expertise in sustainability and experience in community engagement | 1 |
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
VIEW PRODUCTS
© Abcam plc. all rights reserved.
Abcam plc is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
Website by FisherPaul